Viatris completes acquisition of Pacira BioSciences
PCRX•Viatris completed its acquisition of Pacira BioSciences on Nov. 17 for $36.50 per share in cash. The deal is expected to contribute $90 million to $100 million in revenue from Nov. 17 through Dec. 31.




